Urologic Health

Urologic Health LTD, based in Israel, specializes in advanced urodynamic diagnostics, providing innovative tools that enhance patient care within urology. Their focus is on non-invasive technologies that streamline urinary function assessments. Founded in 2024 in Or Yehuda, Israel, Urologic Health is dedicated to improving urological diagnostics. The company raised USD 11.

00 mn in Seed funding on May 14, 2026, led by Edge Medical Ventures, Longevity Venture Partners, and Scientific Health Development. Urologic Health has completed one deal to date, positioning itself as a rising entity in the healthcare sector. Urologic Health specializes in advanced urodynamic diagnostics with a range of non-invasive, robust technologies designed to enhance patient care. Their core products include diagnostic tools that assess urinary function, addressing common urological issues like incontinence and bladder dysfunction.

The company's solutions are utilized by hospitals, urology clinics, and outpatient facilities across North America and Europe. Urologic Health generates revenue through direct sales of diagnostic systems and software, establishing pricing plans for clinics and hospitals. Their flagship products consist of proprietary urodynamic equipment that provides real-time data analysis. Revenue is generated through one-time purchases and recurring subscriptions for software updates and support services, fostering long-term client relationships.

Following its recent Seed funding round of USD 11. 00 mn on May 14, 2026, Urologic Health plans to expand its business operations and development efforts. The company intends to introduce new products aimed at enhancing diagnostic capabilities in urology. Additionally, Urologic Health is targeting expansion into new geographic regions, with specific markets set for future growth.